Assessment of BRAF and KIT mutations in Japanese melanoma patients-Reference-Cited by-同舟云学术

Assessment of BRAF and KIT mutations in Japanese melanoma patients

Published:2012-06 Issue:3 Volume:66 Page:240-242
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Ashida Atsuko,Uhara Hisashi,Kiniwa Yukiko,Oguchi Misae,Murata Hiroshi,Goto Yasufumi,Uchiyama Aya,Ogawa Eisaku,Hayashi Koichi,Koga Hiroshi,Okuyama Ryuhei

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference10 articles.

1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

2. KIT as a therapeutic target in metastatic melanoma;Carvajal;JAMA,2011

3. Distinct sets of genetic alterations in melanoma;Curtin;N Engl J Med,2005

4. Somatic activation of KIT in distinct subtypes of melanoma;Curtin;J Clin Oncol,2006

5. Large-scale analysis of KIT aberrations in Chinese patients with melanoma;Kong;Clin Cancer Res,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD‐1 antibody for BRAF‐mutated melanoma;Cancer Science;2024-06-18

2. Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1;International Journal of Clinical Oncology;2023-11-29

3. Topics of Malignant Melanoma;Journal of Nihon University Medical Association;2022-12-01

4. Genomic profiling with whole‐exome sequencing revealed distinct mutations and novel pathways in Asian melanoma;The Journal of Dermatology;2022-10-02

5. Oral melanoma: a multicenter study of 69 patients from Japan;Clinical Oral Investigations;2022-08-03